I’m The Only One With Genius DNA 21

I’m The Only One With Genius DNA chapter 21

Ambitious (2)

============

“You want me to leave?”

Ryu Young-joon asked back.

“Yeah, there’s no need for a talent like Dr. Ryu to rot in this kind of place.”

Chun Ji-myung smiled brightly.

Seo Jung-mi and Park Dong-hyun nodded softly. Park Dong-hyun said.

“I’ve been thinking the same thing over and over and over again. Dr. Ryu, to be honest, after you leave, our team will be severely persecuted in Eisen again, but we’re used to it, so it’s okay? Dr. Liu, I don’t want to hold you to your ankles.”

“I feel the same way. I saw Dr. Ryu for the first time today, but I really don’t think he should be here if he’s created reverse differentiated stem cell technology.”

Wiring-mi added.

Ryu Young-joon only snooped around for a drink and gave no answer.

“What’s Dr. Ryu’s dream?”

asked Chun Ji-myung.

“A dream?”

“Is it awkward to ask this?”

“No, my dream is… We can conquer one disease faster and save another.”

Chun Ji-myung grinned.

“What a sound dream.”

“A real scientist’s attitude.”

Ko Soon-yeol said while drinking Sprite.

“But we almost forgot all that enthusiasm.”

Chun Ji-myung said.

“My dream is to raise my children well and marry them.”

“Honestly, I think it’s a shame that Dr. Liu is in Eisen, not just in our team. Dr. Liu.”

Park Dong-hyun said.

“But where can I go?”

“Well.”

“The small and medium-sized pharmaceutical companies in Korea are all under Eisen’s shadow. Realistically, the infrastructure is too low. I can’t set it all up and raise it. Just this reverse-differentiated stem cell. If you apply for a gene or virus here, it comes the next day, right? It would have taken a week or two to do it at a small and medium-sized company. The medium distribution route is not set up enough.”

“That’s right.”

“And from now on, we’re going to have to do organ culture or differentiation research with it, but there’s no company in the country that can do it or have research support capabilities.”

There was a moment of melancholy silence.

“There is no real alternative to Eisen.”

Chun Ji-myung said.

If you don’t have one or two pieces of equipment, you can buy it.

However, research infrastructure is a concept that includes human parts. And this is a difficult area to solve with money.

Since it was a top-level pharmaceutical company like Eisen, there are Park Dong-hyun, Jung Hye-rim, and Ko Soon-yeol in the life creation team.

In just a few days, scientists who re-differentiate stem cells into muscle cells, extract methylation data, or produce exom sequencing data are rare in the world.

Reaction chemistry and cell bio are good, but they are not this good.

It is clear that if you leave Eisen, the pace of progress of research work will decrease significantly.

Having no technician means you have to do everything yourself.

For example, let’s say a marmoset monkey with a specific gene is needed as part of a preclinical experiment.

Where can I get it?

This monkey is nowhere in the world. We have to make it.

Then you have to genetically manipulate the fertilized eggs of the monkey, then incubate them, implant them in the female uterus, and wait for the baby to be born. You can only experiment after waiting for it to mature.

In Eisen, the request to the laboratory animal resources center inside the company is over. Genetically modified techniques there produce and send monkeys.

What about small and medium-sized businesses?

There are no people inside the company who can do that.

There are no companies in Korea that accept such high-level work as outsourcing, and overseas services are ridiculously expensive or inferior.

Therefore, Ryu Young-joon should do it himself.

You can do it if you use Rosaline. However, Eisen can proceed with other research and development during that time.

The unimaginable fragmentary problem is that in reality it comes in three dimensions.

In other words, Ryu Young-joon should not produce all of the marmoset monkeys, but also manage, breed, and dispose of them.

Above all, the big problem is that CEOs of the small and medium-sized companies can be swayed by Eisen like Selizenner. No company can work properly if its head is reeling.

What if you start a pharmaceutical company?

The problem of being swayed by Eisen can be prevented somehow, but it goes a long way.

First of all, the Ministry of Health and Welfare and the Ministry of Science and Technology should apply to establish a biology institute.

Permission for the use of genetically modified organisms should be obtained at each laboratory unit of the laboratory.

Five documents are available to purchase laboratory equipment, and to purchase laboratory animals or cell stocks, you must complete the transportation plan, laboratory plan and disposal plan, obtain confirmation and permission.

Management and regulation are as demanding as dangerous substances can occur when leaked to the outside world.

No matter how good Rosaline is, what can she do with the examiners of the authorities?

If you set them up one by one, it will take five years to start one experiment that you were originally planning to do.

“They’re popping stem cells and getting attention, so if they go out, the executives will catch them. Well, I guess you’ll feel good for a second. But there’s no realistic alternative.”

Ryu Young-joon said.

“In Korea, but there are companies as big as Eisen when we go abroad.”

Park Dong-hyun said.

“You know, but they’re no different than Eisen. You know.”

Ryu Young-joon said.

If Eisen executives are like Satan, they are the ones who can retire Satan.

Viciousness is on a different level.

In the third world, it is often the case of conducting human experiments with undeclared minors, or threatening governments with human lives to make a profit of 100 times the production cost.

I didn’t want to work in such a place even if I treated the researcher more.

“I was an intern at Johnson & Johnson. I’d rather not go.”

Jung Hye-rim said.

“There’s a saying that a familiar nut is better than a new nut.”

“Or don’t just go to work and be a professor.”

Chun Ji-myung said.

“After writing a stem cell thesis on Dr. Ryu’s skills, Jeong Yoon University will invite him to teach.”

“But professors don’t have much power. It’s usually basic technology or production, but you can’t make products that can’ I want to create a more helpful force in the world.”

“But working here will help Eisen’s superiors. It’s not helping the world.”

“I don’t think so anymore because I’ve been in the anti-cancer department once.”

“No matter how smart Dr. Ryu is, he’s a paid employee at the company. Whatever Dr. Liu does, he’ll be owned by the company, and the company will be owned by shareholders and executives. To be honest, I’m annoyed and grumpy about Dr. Liu filling them up.”

“They won’t be full thanks to me.”

“But once the counter-differentiated stem cells are in place, the shareholders will share their patent shares.”

“No, I won’t give it to you.”

There was a moment of silence.

Wiring-mi hardened as she raised her glass.

“What are you talking about? Dr. Liu, is that what you want? All patents for technology developed in-house are owned by the company.”

“Owner is a company. But you can apply for the distribution of profits from royalties when the patent applicant hands over to the law office to do this and that.”

“······. I’m getting very nervous all of a sudden, how did you write the royalty share on the patent application?”

asked Chun Ji-myung.

“The first patentee wrote my name. The second patent holder is Sunyeol. Next is Dong Hyun and Hyerim. It’s based on the importance of the data. The manager and the manager weren’t at the company at the time and they didn’t experiment, so it’s a shame, but they don’t have any shares. I spent my share of the shares on my own.”

Clink!

Park Dong-hyun accidentally turned over the cup and made a loud noise.

“Oh, I’m sorry. My hands were shaking.”

“Dr. Ryu, did you really write that? Dr. Liu used the share?

asked Chun Ji-myung.

“Yes.”

“That’s crazy ·····.”

Eisen’s patent application method is unique.

The researcher, who is the first inventor, develops the technology and writes an application for patent application. At this point, the first inventor can specify the patent stake. Like Ryu Young-joon now.

This is a rule that arose when the company was a startup. It was created based on the idea of a researcher-centered company, but it doesn’t mean much now.

This is because executives will review the documents after they are prepared at the law office anyway.

If the shares written by the first-term researcher do not suit the executives’ taste, they can return them, or call the researcher to the executive office to mash them and revise them.

Employees have little power, so they have no choice but to follow.

If that continues for decades, it becomes a kind of culture that a researcher can initially specify a patent stake.

Now, most researchers fill out applications without using the patent share at all.

And before you send it to the law office, you submit it to the research support department of the lab. Then, the research support department will take orders from the head of the research center to appropriately use the shares and send them to the legal office.

Young scientists think it is a rule to do so at all.

There is a reason why there was no backlash among scientists.

For now, most patents are not commercialized, so they’re barely moneyable. That’s why no one cares.

And in the case of occasional “money-making patents,” at least a few years before filing, at least dozens of scientists rush in and study all night.

In other words, the patent for money is necessarily a super-large project, which takes a lot of money, manpower, and time.

For example, if reverse differentiated stem cell technology had been set up without Rosaline, how much support would Eisen have to offer at the headquarters?

This type of patent is a case that the company already knows and fully supports from the beginning of the research.

By then, the meaning of dividing the shares among the first-line researchers will fade at the end of the project.

There are about 200 participating scientists, and it is difficult to give all of them a stake.

Naturally, only a few key personnel will receive a formal share in decimal places, and the rest will be rewarded as performance-based bonuses.

What about the rest of the shares?

Shareholders share it in the name of the company or in meetings.

That way, no one has any complaints. In this case, it is also a matter of course.

This is because it is impossible to ignore the contribution of the head of the research center, research support department, and Eisen headquarters, who have spent a lot of money behind the scenes to carry out a project for several years.

However, Ryu Young-joon’s situation is very different.

This could have happened because it was such an exceptional case. Chun Ji-myung broke out in a cold sweat.

“You’re so crazy ·····. I can’t believe Dr. Ryu wrote down all the shares. And you didn’t put our research director Gil Hyungjun or CTO in there? Did you send him to the law office in that condition?”

“Dr. Ryu, the names of the executives must be included.”

Wiring-mi said worriedly.

“What are you talking about?”

Ryu Young-joon is serious.

“They didn’t even know I was doing that kind of research until I presented the results at the seminar. But why do you have a stake? That’s a violation of research ethics.”

Silence fell on the table again.

“Call, call, call, call, call, call, call, call, call. Honmono ····.”

Suddenly, Ko Soon-yeol muttered.

“It’s not just a strict principler, it’s ·····. This person is ·····. Real honmono ····.”

“Science should be done by the book. It’s the study of objectivity, and it’s the purest.”

Ryu Young-joon said.

“I agree.”

Chun Ji-myung said.

But I don`t know if Gil Hyung-joon or executives will agree on that. Nicholas is a genuine scientist and a principled scientist like Dr. Ryu, so in this case, he may say yes.”

“You skipped the research support department and transferred it directly to the law office at lab six, right?”

asked Wirwumi.

“Yes.”

“Then as soon as I’m done filling out the documents, I’ll go to the research support department of the lab and go to Gil Hyung-joon. It’s going to turn upside down ·····.”

“I’ll take care of it. You don’t have to worry.”

“Tell me the percentage of royalty shares in detail.”

Chun Ji-myeong said anxiously.

“In the case of a patent of great potential, no individual is allowed to take more than 10 percent. So I’m 10% sure. Dong Hyun, Hyerim and Soonyeol are 3% each.”

“What about the rest?”

“We used Eizen equipment to develop it, and Eizen will do patent registration in the future, so we gave 0.5 percent to Eizen’s 6th lab and headquarters.”

“So there’s 80 percent left?”

“There’s a clause in the in-house patent section that states that more than 80% of the shares must be returned to the company’s name. So I spent all of it on the Life Creation Department budget.”

“Department budget?”

“The name of the company is Eisen’s headquarters and six research institutes. Actually, it’s not per department, but I just wrote it. I didn’t want the health food department to spend this money. And I’m going to write a separate contract to finalize the budget and get the final approval right in my name.”

“······.”

“Youngjun, are you a regressor?”

asked Ko Soon-yeol.

“Oh, I’m not. What is it, man?”

“A 60-year-old company executive seems to be returning to his youth and getting revenge for his blood.”

“Dr. Liu, how are you going to defend Eisen’s management and directors if they’re trying to eat that patent stake? I think you’ve got some ridiculous terms.”

Jung Hye-rim asked.

“Just wait and see. I have something in mind.”

Ryu Young-joon said with a smile.

“Dr. Ryu.”

Chun Ji-myung said.

“If Dr. Liu’s dream was to make one faster and get one more person, it would be faster to dedicate it to the executives and ask for cooperation.”

“I guess so.”

“But I think there’s a different point in trying to secure independent research budgets and authorization rights while fighting with management. What does Dr. Liu want?”

“What I want?”

“I just want to help if I can.”

“Well, I’m counting on my team members. I’ll tell you the truth because I think everyone will snort and drop it in one ear even if the conversation goes elsewhere. First of all, my dream is what I told you earlier.”

Ryu Young-joon said.

“I intend to become Eisen’s largest shareholder and chief executive with the aim of achieving that.”

“······.”

There was silence on the table again.

“Do you think it’s a little absurd? But no matter how hard I think about it, that’s the only way. There are few companies overseas that have better hardware than Ezen. The problem is, there’s a virus in the OS here. I’m going to format it and reinstall it.”

Park Dong-hyun raised his hand.

“I don’t want to say it’s difficult or not. Honestly, the reverse differentiated stem cells were almost like science fiction, right? But he did it in a week, didn’t he? I’m on Dr. Ryu’s side.”

“If Dr. Ryu succeeds, he may be hired as a substitute manager, but the biggest shareholder is not easy. It’s like being the owner of the company. You know that, don’t you?”

Chun Ji-myung said.

“Yes.”

“Even with a lot of money, it’s hard to buy that much stock. I’ll stop you from defending management.”

“Now is the time. But it will change in the future. The reverse differentiated stem cells will revolutionize in a few years, and I’m sure there will be conscientious scientists inside Eisen to support me. Then there will be some of the major shareholders who turn to my side. I’m going to buy shares from them.”

“Ha. I’m sure it’ll work out well, but ·····.”

Cheon Ji-myeong smiled in vain.

Park Dong-hyun said.

“Dr. Ryu, I mean when reverse differentiated stem cells become commercial and start to cure all kinds of diseases. I think Dr. Ryu’s reputation and wealth will go up and challenge his management rights.”

Park Dong-hyun said.

“If that’s the time, let me head that life-creation team. I’m rattling in advance.”

Cheon Ji-myeong stared at him as if he was dumbfounded.

“Then what about me?”

“It must have been about 20 years by then, but you should retire and farm somewhere in the countryside. I dig up winter spinach and sometimes watch my grandchildren’s tricks.”

“This is a total lunatic ······.

Ryu Young-joon smirked.

It won’t take 20 years. We’ll do it as soon as we can.”

“Yes, if Dr. Liu does anything later, I’ll do everything I can to help.”

“Me, too.”

Jung Hye-rim said.

“I can do it from now on. Dr. Liu, what should I do?”

When Park Dong-hyun played a joke, Wiring-mi glanced at him.

“Dong Hyun, your tension is really good today. Why are you so excited?”

“It’s so thrilling to think of Dr. Ryu becoming Eisenhead. Dr. Liu, please reform and lead this rotten company. I’ve grown attached to him a lot.”

“Anyway, what is certain now is that by Monday, Gil Hyung-joon, who has read the patent documents, will come to our department with something like an iron pipe. Is that it?

Chun Ji-myung said.

“I expect a hammer.”

Park Dong-hyun said.

“I’m a chainsaw.”

Jung Hye-rim said.

“······.”

“Stop talking nonsense and make a toast.”

Ryu Young-joon held a glass.

I’m The Only One With Genius DNA chapter 21

|

ToC

|